Susan Majka
Concepts (390)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lung | 24 | 2024 | 3940 | 2.500 |
Why?
| Wnt Signaling Pathway | 6 | 2023 | 170 | 1.930 |
Why?
| Neovascularization, Pathologic | 3 | 2025 | 297 | 1.540 |
Why?
| Pulmonary Fibrosis | 5 | 2025 | 385 | 1.470 |
Why?
| Stem Cells | 14 | 2023 | 578 | 1.360 |
Why?
| Hypertension, Pulmonary | 17 | 2022 | 1897 | 1.240 |
Why?
| Neovascularization, Physiologic | 4 | 2020 | 176 | 1.210 |
Why?
| Cell Separation | 6 | 2020 | 316 | 1.150 |
Why?
| Microvessels | 3 | 2025 | 82 | 1.080 |
Why?
| Adipocytes | 7 | 2022 | 205 | 1.020 |
Why?
| Cell Lineage | 10 | 2020 | 332 | 1.010 |
Why?
| Cell Differentiation | 19 | 2021 | 1900 | 0.970 |
Why?
| Endothelial Progenitor Cells | 2 | 2025 | 20 | 0.930 |
Why?
| Adipose Tissue | 9 | 2022 | 594 | 0.920 |
Why?
| Capillaries | 1 | 2025 | 103 | 0.910 |
Why?
| Stem Cell Niche | 3 | 2020 | 53 | 0.830 |
Why?
| Mice | 41 | 2025 | 16983 | 0.830 |
Why?
| Lung Injury | 4 | 2019 | 211 | 0.810 |
Why?
| Pulmonary Alveoli | 1 | 2025 | 403 | 0.780 |
Why?
| beta Catenin | 3 | 2020 | 224 | 0.770 |
Why?
| Pulmonary Disease, Chronic Obstructive | 7 | 2023 | 1000 | 0.750 |
Why?
| Endothelium, Vascular | 5 | 2020 | 902 | 0.730 |
Why?
| Fibrosis | 4 | 2019 | 526 | 0.710 |
Why?
| Animals | 55 | 2025 | 35409 | 0.710 |
Why?
| TOR Serine-Threonine Kinases | 1 | 2023 | 398 | 0.700 |
Why?
| Airway Remodeling | 1 | 2020 | 64 | 0.660 |
Why?
| Myeloid Cells | 4 | 2019 | 142 | 0.660 |
Why?
| Wnt Proteins | 1 | 2020 | 126 | 0.630 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2020 | 373 | 0.610 |
Why?
| Polycystic Kidney Diseases | 1 | 2019 | 68 | 0.600 |
Why?
| Bone Marrow Cells | 7 | 2021 | 302 | 0.600 |
Why?
| Immunophenotyping | 1 | 2020 | 310 | 0.600 |
Why?
| Cells, Cultured | 15 | 2020 | 4102 | 0.590 |
Why?
| Bone Morphogenetic Protein Receptors, Type II | 4 | 2017 | 51 | 0.590 |
Why?
| Pericytes | 2 | 2017 | 28 | 0.580 |
Why?
| PPAR gamma | 5 | 2022 | 183 | 0.570 |
Why?
| Leukocyte Common Antigens | 5 | 2011 | 82 | 0.530 |
Why?
| Pulmonary Artery | 11 | 2022 | 1097 | 0.510 |
Why?
| Flow Cytometry | 7 | 2018 | 1160 | 0.500 |
Why?
| Endothelial Cells | 5 | 2022 | 749 | 0.500 |
Why?
| Myocytes, Smooth Muscle | 7 | 2020 | 259 | 0.490 |
Why?
| Cell- and Tissue-Based Therapy | 3 | 2016 | 77 | 0.480 |
Why?
| Adipocytes, White | 2 | 2015 | 17 | 0.470 |
Why?
| ATP-Binding Cassette Transporters | 2 | 2014 | 133 | 0.450 |
Why?
| Mesoderm | 4 | 2010 | 138 | 0.440 |
Why?
| Mice, Inbred C57BL | 18 | 2025 | 5468 | 0.430 |
Why?
| Pluripotent Stem Cells | 1 | 2014 | 77 | 0.420 |
Why?
| Cell Proliferation | 8 | 2018 | 2378 | 0.390 |
Why?
| Lung Diseases | 4 | 2016 | 743 | 0.380 |
Why?
| Bleomycin | 3 | 2019 | 243 | 0.370 |
Why?
| Neoplasm Proteins | 1 | 2014 | 417 | 0.370 |
Why?
| Induced Pluripotent Stem Cells | 2 | 2011 | 221 | 0.360 |
Why?
| Calcification, Physiologic | 1 | 2011 | 33 | 0.350 |
Why?
| Benzimidazoles | 2 | 2011 | 162 | 0.350 |
Why?
| Mice, Transgenic | 12 | 2022 | 2135 | 0.350 |
Why?
| Pulmonary Circulation | 3 | 2009 | 431 | 0.350 |
Why?
| Intra-Abdominal Fat | 1 | 2011 | 88 | 0.350 |
Why?
| Osteoblasts | 1 | 2011 | 117 | 0.330 |
Why?
| Pulmonary Emphysema | 3 | 2022 | 275 | 0.330 |
Why?
| Fibroblast Growth Factor 10 | 3 | 2019 | 23 | 0.320 |
Why?
| Familial Primary Pulmonary Hypertension | 5 | 2014 | 199 | 0.320 |
Why?
| Disease Models, Animal | 9 | 2025 | 4077 | 0.320 |
Why?
| Osteogenesis | 1 | 2011 | 175 | 0.310 |
Why?
| Hypoxia | 9 | 2021 | 1087 | 0.310 |
Why?
| Regeneration | 5 | 2019 | 182 | 0.290 |
Why?
| Respiratory System | 1 | 2009 | 156 | 0.290 |
Why?
| Phenotype | 7 | 2020 | 3062 | 0.280 |
Why?
| Humans | 39 | 2024 | 129847 | 0.270 |
Why?
| Mice, Knockout | 7 | 2021 | 2888 | 0.260 |
Why?
| Immunomodulation | 2 | 2021 | 92 | 0.250 |
Why?
| Mutation | 2 | 2021 | 3706 | 0.250 |
Why?
| Myofibroblasts | 2 | 2019 | 121 | 0.250 |
Why?
| Apoptosis | 4 | 2013 | 2489 | 0.250 |
Why?
| Vasoconstriction | 2 | 2017 | 199 | 0.240 |
Why?
| Matrix Metalloproteinase 2 | 2 | 2002 | 56 | 0.240 |
Why?
| Superoxide Dismutase | 3 | 2014 | 342 | 0.230 |
Why?
| Respiratory Mucosa | 2 | 2019 | 310 | 0.220 |
Why?
| Vascular Remodeling | 3 | 2022 | 192 | 0.220 |
Why?
| Pneumoconiosis | 1 | 2024 | 19 | 0.220 |
Why?
| Coal Mining | 1 | 2024 | 23 | 0.220 |
Why?
| Cell Line | 3 | 2020 | 2780 | 0.210 |
Why?
| Polymorphism, Single Nucleotide | 2 | 2023 | 2062 | 0.200 |
Why?
| T-Lymphocytes | 1 | 2011 | 1937 | 0.200 |
Why?
| Muscle, Smooth, Vascular | 4 | 2015 | 444 | 0.200 |
Why?
| Granuloma, Respiratory Tract | 1 | 2002 | 11 | 0.200 |
Why?
| Cryptococcus neoformans | 1 | 2002 | 19 | 0.190 |
Why?
| Cryptococcosis | 1 | 2002 | 26 | 0.190 |
Why?
| Leptin | 2 | 2022 | 222 | 0.190 |
Why?
| Retinal Neovascularization | 1 | 2002 | 25 | 0.190 |
Why?
| Epithelial Cells | 4 | 2020 | 1063 | 0.180 |
Why?
| Cell Hypoxia | 2 | 2020 | 234 | 0.180 |
Why?
| Urokinase-Type Plasminogen Activator | 2 | 1999 | 29 | 0.180 |
Why?
| Hemopexin | 1 | 2021 | 27 | 0.180 |
Why?
| Potassium Channels, Tandem Pore Domain | 1 | 2021 | 14 | 0.180 |
Why?
| Matrix Metalloproteinases | 1 | 2002 | 91 | 0.180 |
Why?
| Acute Lung Injury | 2 | 2017 | 280 | 0.180 |
Why?
| Tamoxifen | 2 | 2019 | 197 | 0.180 |
Why?
| Cigarette Smoking | 1 | 2022 | 91 | 0.180 |
Why?
| Fibroblasts | 3 | 2018 | 954 | 0.180 |
Why?
| Calgranulin B | 1 | 2020 | 9 | 0.180 |
Why?
| Proto-Oncogene Proteins pp60(c-src) | 1 | 2020 | 12 | 0.170 |
Why?
| Occupational Exposure | 1 | 2024 | 302 | 0.170 |
Why?
| Myocardium | 4 | 2019 | 983 | 0.170 |
Why?
| Glutathione Peroxidase | 1 | 2020 | 43 | 0.170 |
Why?
| Male | 19 | 2020 | 63759 | 0.170 |
Why?
| Gene Expression Regulation, Developmental | 2 | 2011 | 820 | 0.160 |
Why?
| Muscle, Skeletal | 3 | 2009 | 1644 | 0.160 |
Why?
| Hematopoietic Stem Cells | 6 | 2022 | 382 | 0.160 |
Why?
| Selective Estrogen Receptor Modulators | 1 | 2019 | 28 | 0.160 |
Why?
| Biomarkers | 5 | 2021 | 3971 | 0.160 |
Why?
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2019 | 24 | 0.160 |
Why?
| Vascular System Injuries | 1 | 2020 | 73 | 0.160 |
Why?
| Cell Culture Techniques | 2 | 2020 | 349 | 0.160 |
Why?
| RNA Stability | 1 | 2020 | 103 | 0.160 |
Why?
| Smoke | 1 | 2020 | 140 | 0.160 |
Why?
| Receptor, Serotonin, 5-HT2B | 1 | 2018 | 2 | 0.160 |
Why?
| Myeloid Progenitor Cells | 1 | 2018 | 17 | 0.150 |
Why?
| Kidney Tubules, Proximal | 1 | 2019 | 125 | 0.150 |
Why?
| Cyclic AMP Response Element-Binding Protein | 2 | 2011 | 141 | 0.150 |
Why?
| Alveolar Epithelial Cells | 1 | 2019 | 107 | 0.150 |
Why?
| Laryngostenosis | 1 | 2018 | 47 | 0.150 |
Why?
| Cicatrix | 1 | 2018 | 63 | 0.140 |
Why?
| Benzaldehydes | 1 | 2017 | 10 | 0.140 |
Why?
| Interleukin-17 | 1 | 2018 | 110 | 0.140 |
Why?
| Cadherins | 1 | 2019 | 190 | 0.140 |
Why?
| Membrane Proteins | 2 | 2022 | 1119 | 0.140 |
Why?
| Female | 16 | 2022 | 68829 | 0.140 |
Why?
| Anemia, Sickle Cell | 1 | 2021 | 253 | 0.140 |
Why?
| Inflammation Mediators | 1 | 2020 | 505 | 0.140 |
Why?
| Niacinamide | 1 | 2017 | 75 | 0.140 |
Why?
| Ventricular Remodeling | 1 | 2019 | 256 | 0.140 |
Why?
| Nerve Tissue Proteins | 1 | 2021 | 569 | 0.140 |
Why?
| Integrin beta1 | 1 | 2017 | 22 | 0.140 |
Why?
| Thiazolidinediones | 2 | 2009 | 137 | 0.140 |
Why?
| Heart | 2 | 1999 | 645 | 0.140 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2002 | 1205 | 0.130 |
Why?
| Protein Stability | 1 | 2017 | 162 | 0.130 |
Why?
| Signal Transduction | 8 | 2019 | 4935 | 0.130 |
Why?
| MicroRNAs | 1 | 2022 | 680 | 0.130 |
Why?
| Hemoglobins | 2 | 2021 | 339 | 0.120 |
Why?
| Hypoxia-Inducible Factor 1 | 1 | 2015 | 72 | 0.120 |
Why?
| Trans-Activators | 1 | 1997 | 392 | 0.120 |
Why?
| Promoter Regions, Genetic | 3 | 2015 | 1213 | 0.110 |
Why?
| Gene Expression Regulation | 5 | 2022 | 2545 | 0.110 |
Why?
| Repressor Proteins | 1 | 1997 | 404 | 0.110 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2022 | 274 | 0.110 |
Why?
| Inflammation | 3 | 2022 | 2748 | 0.110 |
Why?
| Proto-Oncogene Proteins | 1 | 1997 | 634 | 0.110 |
Why?
| Cell Fusion | 2 | 2015 | 51 | 0.110 |
Why?
| Transforming Growth Factor beta1 | 1 | 2014 | 158 | 0.110 |
Why?
| Genetic Predisposition to Disease | 3 | 2021 | 2271 | 0.110 |
Why?
| Vascular Stiffness | 1 | 2018 | 467 | 0.110 |
Why?
| Animals, Newborn | 2 | 2009 | 834 | 0.110 |
Why?
| Aging | 1 | 2023 | 1774 | 0.110 |
Why?
| Adult | 5 | 2020 | 35634 | 0.110 |
Why?
| Leukocytes, Mononuclear | 2 | 2022 | 546 | 0.110 |
Why?
| Insulin | 2 | 2022 | 2330 | 0.100 |
Why?
| Macrophages | 3 | 2022 | 1489 | 0.100 |
Why?
| Hydrogen Peroxide | 2 | 2012 | 317 | 0.100 |
Why?
| Polymerase Chain Reaction | 2 | 2018 | 1033 | 0.100 |
Why?
| Fatty Acid-Binding Proteins | 2 | 2023 | 68 | 0.100 |
Why?
| Models, Biological | 4 | 2021 | 1724 | 0.100 |
Why?
| Class Ia Phosphatidylinositol 3-Kinase | 1 | 2012 | 7 | 0.100 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2006 | 954 | 0.100 |
Why?
| ADAM Proteins | 2 | 2022 | 59 | 0.100 |
Why?
| Myocardial Infarction | 1 | 2019 | 1021 | 0.100 |
Why?
| Early Growth Response Protein 1 | 2 | 2010 | 28 | 0.100 |
Why?
| Cytological Techniques | 1 | 2011 | 27 | 0.090 |
Why?
| Receptor, TIE-2 | 1 | 2011 | 12 | 0.090 |
Why?
| Receptors, Immunologic | 1 | 2013 | 216 | 0.090 |
Why?
| Mice, Nude | 2 | 2011 | 680 | 0.090 |
Why?
| Ventricular Pressure | 1 | 2011 | 45 | 0.090 |
Why?
| Regenerative Medicine | 1 | 2011 | 46 | 0.090 |
Why?
| Integrin-Binding Sialoprotein | 1 | 2011 | 5 | 0.090 |
Why?
| Osteocalcin | 1 | 2011 | 36 | 0.090 |
Why?
| Mice, Inbred ICR | 1 | 2011 | 111 | 0.090 |
Why?
| Diet, High-Fat | 1 | 2012 | 239 | 0.090 |
Why?
| Oligonucleotide Array Sequence Analysis | 2 | 2010 | 756 | 0.090 |
Why?
| Adipocytes, Brown | 1 | 2010 | 7 | 0.090 |
Why?
| World Health Organization | 1 | 2011 | 110 | 0.090 |
Why?
| Bone Morphogenetic Proteins | 1 | 2011 | 129 | 0.090 |
Why?
| Cytogenetic Analysis | 1 | 2010 | 32 | 0.090 |
Why?
| DNA-Binding Proteins | 1 | 1997 | 1441 | 0.080 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2012 | 362 | 0.080 |
Why?
| Lymphoid Progenitor Cells | 1 | 2009 | 11 | 0.080 |
Why?
| Extracellular Space | 1 | 2010 | 120 | 0.080 |
Why?
| Gene Expression Profiling | 2 | 2021 | 1686 | 0.080 |
Why?
| Vascular Diseases | 1 | 2012 | 240 | 0.080 |
Why?
| Bronchoconstriction | 1 | 2009 | 31 | 0.080 |
Why?
| RNA, Messenger | 4 | 2009 | 2703 | 0.080 |
Why?
| Syndecan-4 | 1 | 2009 | 7 | 0.080 |
Why?
| Ventricular Function, Right | 1 | 2011 | 276 | 0.080 |
Why?
| Genotype | 2 | 2011 | 1829 | 0.080 |
Why?
| AC133 Antigen | 1 | 2008 | 19 | 0.080 |
Why?
| Giant Cells | 1 | 2008 | 23 | 0.080 |
Why?
| Satellite Cells, Skeletal Muscle | 1 | 2009 | 29 | 0.080 |
Why?
| Neprilysin | 1 | 2009 | 48 | 0.080 |
Why?
| Case-Control Studies | 4 | 2021 | 3384 | 0.080 |
Why?
| Tissue Scaffolds | 1 | 2011 | 203 | 0.070 |
Why?
| Hyperoxia | 1 | 2009 | 90 | 0.070 |
Why?
| Muscle, Smooth | 1 | 2009 | 160 | 0.070 |
Why?
| Infant, Newborn, Diseases | 1 | 2009 | 111 | 0.070 |
Why?
| Thrombosis | 1 | 2011 | 349 | 0.070 |
Why?
| Middle Aged | 5 | 2020 | 31177 | 0.070 |
Why?
| Vasodilator Agents | 1 | 2009 | 326 | 0.070 |
Why?
| Receptor for Advanced Glycation End Products | 2 | 2020 | 31 | 0.070 |
Why?
| Activating Transcription Factor 1 | 1 | 2006 | 9 | 0.070 |
Why?
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2006 | 14 | 0.070 |
Why?
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2006 | 32 | 0.070 |
Why?
| Glycoproteins | 1 | 2008 | 338 | 0.070 |
Why?
| Immunohistochemistry | 2 | 2018 | 1690 | 0.060 |
Why?
| RNA, Small Interfering | 4 | 2011 | 590 | 0.060 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2009 | 528 | 0.060 |
Why?
| Reactive Oxygen Species | 1 | 2009 | 592 | 0.060 |
Why?
| Cell Nucleus | 1 | 2009 | 590 | 0.060 |
Why?
| Antigens, CD | 1 | 2008 | 487 | 0.060 |
Why?
| Bone Marrow Transplantation | 3 | 2019 | 277 | 0.060 |
Why?
| Cytokines | 3 | 2021 | 2022 | 0.060 |
Why?
| Pyrroles | 2 | 2018 | 202 | 0.060 |
Why?
| Age Factors | 2 | 2010 | 3161 | 0.060 |
Why?
| Adiponectin | 2 | 2022 | 236 | 0.060 |
Why?
| Sex Factors | 1 | 2010 | 1973 | 0.060 |
Why?
| Silicates | 1 | 2024 | 15 | 0.060 |
Why?
| Coal | 1 | 2024 | 18 | 0.060 |
Why?
| Aged | 3 | 2020 | 22107 | 0.050 |
Why?
| Insulin Resistance | 1 | 2012 | 1168 | 0.050 |
Why?
| Young Adult | 1 | 2020 | 12467 | 0.050 |
Why?
| Microscopy, Electron, Scanning | 1 | 2024 | 196 | 0.050 |
Why?
| Dust | 1 | 2024 | 94 | 0.050 |
Why?
| Blotting, Western | 3 | 2012 | 1204 | 0.050 |
Why?
| Sepsis | 1 | 2009 | 576 | 0.050 |
Why?
| Muscle Cells | 1 | 2003 | 43 | 0.050 |
Why?
| Guanine | 1 | 2003 | 76 | 0.050 |
Why?
| Wound Healing | 2 | 2003 | 308 | 0.050 |
Why?
| Hypertrophy, Right Ventricular | 2 | 2014 | 145 | 0.050 |
Why?
| Indoles | 2 | 2018 | 387 | 0.050 |
Why?
| Peptides | 1 | 2008 | 926 | 0.050 |
Why?
| Silicon Dioxide | 1 | 2024 | 109 | 0.050 |
Why?
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 2002 | 15 | 0.050 |
Why?
| Enzyme-Linked Immunosorbent Assay | 2 | 2018 | 836 | 0.050 |
Why?
| Endothelium | 1 | 2003 | 121 | 0.050 |
Why?
| Stem Cell Transplantation | 4 | 2006 | 166 | 0.050 |
Why?
| X-Ray Microtomography | 1 | 2022 | 84 | 0.050 |
Why?
| Diphtheria Toxin | 1 | 2022 | 65 | 0.050 |
Why?
| ADAM17 Protein | 1 | 2002 | 33 | 0.050 |
Why?
| Ceramides | 1 | 2022 | 112 | 0.050 |
Why?
| Multipotent Stem Cells | 1 | 2002 | 19 | 0.050 |
Why?
| Metalloendopeptidases | 1 | 2002 | 60 | 0.050 |
Why?
| In Situ Nick-End Labeling | 1 | 2002 | 123 | 0.050 |
Why?
| Nitric Oxide Synthase Type III | 2 | 2014 | 203 | 0.050 |
Why?
| Quail | 2 | 1999 | 6 | 0.050 |
Why?
| Immunoenzyme Techniques | 1 | 2002 | 211 | 0.050 |
Why?
| Leukocyte Count | 1 | 2002 | 326 | 0.050 |
Why?
| Matrix Metalloproteinase 9 | 1 | 2002 | 124 | 0.050 |
Why?
| Receptors, Tumor Necrosis Factor | 1 | 2002 | 161 | 0.050 |
Why?
| Heme | 1 | 2021 | 77 | 0.040 |
Why?
| Leukocytes | 1 | 2022 | 306 | 0.040 |
Why?
| Phosphoproteins | 2 | 2017 | 333 | 0.040 |
Why?
| Cell Division | 3 | 2009 | 790 | 0.040 |
Why?
| Hematopoiesis | 1 | 2001 | 184 | 0.040 |
Why?
| Models, Animal | 1 | 2002 | 376 | 0.040 |
Why?
| Hemolysis | 1 | 2021 | 199 | 0.040 |
Why?
| Enzyme Inhibitors | 1 | 2003 | 827 | 0.040 |
Why?
| Vital Capacity | 1 | 2020 | 290 | 0.040 |
Why?
| Rats | 3 | 2013 | 5487 | 0.040 |
Why?
| Disease Susceptibility | 1 | 2021 | 334 | 0.040 |
Why?
| Lymphocytes | 1 | 2021 | 377 | 0.040 |
Why?
| Epithelium | 1 | 2020 | 311 | 0.040 |
Why?
| Benzodioxoles | 1 | 2020 | 106 | 0.040 |
Why?
| Obesity | 1 | 2012 | 2885 | 0.040 |
Why?
| Hepatocyte Growth Factor | 1 | 1999 | 34 | 0.040 |
Why?
| Arterioles | 1 | 2018 | 50 | 0.040 |
Why?
| Quinazolines | 1 | 2020 | 243 | 0.040 |
Why?
| Enzyme Activation | 1 | 2020 | 813 | 0.040 |
Why?
| Monocytes | 1 | 2021 | 554 | 0.040 |
Why?
| Biopsy, Needle | 1 | 2018 | 187 | 0.040 |
Why?
| Proto-Oncogene Protein c-ets-2 | 1 | 1997 | 3 | 0.040 |
Why?
| Cell Adhesion | 1 | 2019 | 455 | 0.040 |
Why?
| Infant, Newborn | 1 | 2009 | 5772 | 0.040 |
Why?
| Transfection | 2 | 2013 | 918 | 0.040 |
Why?
| DNA Primers | 2 | 2009 | 508 | 0.040 |
Why?
| Proto-Oncogene Proteins c-ets | 1 | 1997 | 53 | 0.030 |
Why?
| Regulatory Sequences, Nucleic Acid | 1 | 1997 | 88 | 0.030 |
Why?
| Drug Evaluation, Preclinical | 1 | 2017 | 171 | 0.030 |
Why?
| Embryo, Nonmammalian | 1 | 1997 | 167 | 0.030 |
Why?
| Angiogenesis Inhibitors | 1 | 2018 | 218 | 0.030 |
Why?
| Rats, Sprague-Dawley | 2 | 2013 | 2403 | 0.030 |
Why?
| Reference Values | 1 | 2018 | 796 | 0.030 |
Why?
| Adipogenesis | 1 | 2017 | 51 | 0.030 |
Why?
| Fibrin | 1 | 2017 | 70 | 0.030 |
Why?
| Bioengineering | 1 | 2016 | 19 | 0.030 |
Why?
| Echocardiography | 1 | 2019 | 636 | 0.030 |
Why?
| Blood Pressure | 2 | 2014 | 1736 | 0.030 |
Why?
| Disease Progression | 1 | 2023 | 2628 | 0.030 |
Why?
| Hemodynamics | 2 | 2012 | 1094 | 0.030 |
Why?
| RNA | 1 | 2002 | 877 | 0.030 |
Why?
| Transcriptome | 1 | 2021 | 875 | 0.030 |
Why?
| GTP Cyclohydrolase | 1 | 2014 | 8 | 0.030 |
Why?
| Muscle Development | 2 | 2009 | 108 | 0.030 |
Why?
| Soluble Guanylyl Cyclase | 1 | 2014 | 15 | 0.030 |
Why?
| Treatment Outcome | 1 | 2009 | 10241 | 0.030 |
Why?
| Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2014 | 22 | 0.030 |
Why?
| Guanylate Cyclase | 1 | 2014 | 35 | 0.030 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 399 | 0.030 |
Why?
| Estrogen Antagonists | 1 | 2014 | 46 | 0.030 |
Why?
| Cyclic GMP | 1 | 2014 | 90 | 0.030 |
Why?
| Heart Ventricles | 1 | 2019 | 781 | 0.030 |
Why?
| Lipopolysaccharides | 1 | 2017 | 872 | 0.030 |
Why?
| Genome, Human | 1 | 2016 | 393 | 0.030 |
Why?
| Sensitivity and Specificity | 1 | 2018 | 1847 | 0.030 |
Why?
| Monocrotaline | 1 | 2013 | 28 | 0.030 |
Why?
| S100 Proteins | 1 | 2013 | 35 | 0.030 |
Why?
| Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 216 | 0.030 |
Why?
| Smoking | 1 | 2020 | 1502 | 0.020 |
Why?
| Cyclic N-Oxides | 1 | 2012 | 29 | 0.020 |
Why?
| Chronic Disease | 2 | 2009 | 1724 | 0.020 |
Why?
| Infusion Pumps | 1 | 2012 | 32 | 0.020 |
Why?
| Spin Labels | 1 | 2012 | 46 | 0.020 |
Why?
| Societies, Medical | 1 | 2016 | 759 | 0.020 |
Why?
| Glycation End Products, Advanced | 1 | 2013 | 76 | 0.020 |
Why?
| Arterial Pressure | 1 | 2013 | 119 | 0.020 |
Why?
| Lipid Peroxidation | 1 | 2012 | 152 | 0.020 |
Why?
| Cardiac Output | 1 | 2012 | 157 | 0.020 |
Why?
| Intercellular Adhesion Molecule-1 | 1 | 2012 | 135 | 0.020 |
Why?
| Proteins | 1 | 1997 | 944 | 0.020 |
Why?
| Rats, Inbred WKY | 1 | 2011 | 35 | 0.020 |
Why?
| Hematopoietic Stem Cell Transplantation | 1 | 2017 | 577 | 0.020 |
Why?
| Time Factors | 1 | 2002 | 6550 | 0.020 |
Why?
| Free Radical Scavengers | 1 | 2011 | 83 | 0.020 |
Why?
| Naphthalenes | 1 | 2011 | 57 | 0.020 |
Why?
| STAT3 Transcription Factor | 1 | 2013 | 194 | 0.020 |
Why?
| RNA Interference | 1 | 2013 | 451 | 0.020 |
Why?
| Gene Expression | 2 | 2008 | 1465 | 0.020 |
Why?
| Nitrosation | 1 | 2010 | 8 | 0.020 |
Why?
| Colony-Forming Units Assay | 1 | 2009 | 90 | 0.020 |
Why?
| Risk Factors | 1 | 2023 | 9801 | 0.020 |
Why?
| Up-Regulation | 1 | 2013 | 836 | 0.020 |
Why?
| Genome-Wide Association Study | 1 | 2016 | 1326 | 0.020 |
Why?
| Epithelial-Mesenchymal Transition | 1 | 2011 | 201 | 0.020 |
Why?
| Transcription Factors | 1 | 1997 | 1645 | 0.020 |
Why?
| Tyrosine | 1 | 2010 | 223 | 0.020 |
Why?
| Syndecan-3 | 1 | 2009 | 7 | 0.020 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2011 | 434 | 0.020 |
Why?
| PAX7 Transcription Factor | 1 | 2009 | 13 | 0.020 |
Why?
| Active Transport, Cell Nucleus | 1 | 2009 | 113 | 0.020 |
Why?
| Neoplasms | 1 | 2003 | 2454 | 0.020 |
Why?
| Child | 1 | 2008 | 20962 | 0.020 |
Why?
| Capillary Permeability | 1 | 2009 | 141 | 0.020 |
Why?
| Transforming Growth Factor beta | 1 | 2010 | 462 | 0.020 |
Why?
| Perilipin-1 | 1 | 2006 | 17 | 0.020 |
Why?
| Transcriptional Activation | 1 | 2009 | 366 | 0.020 |
Why?
| Microscopy, Phase-Contrast | 1 | 2006 | 17 | 0.020 |
Why?
| Stress, Physiological | 1 | 2010 | 412 | 0.020 |
Why?
| Nitric Oxide | 1 | 2012 | 896 | 0.020 |
Why?
| Collagenases | 1 | 2006 | 24 | 0.020 |
Why?
| 3T3-L1 Cells | 1 | 2006 | 34 | 0.020 |
Why?
| CD11 Antigens | 1 | 2006 | 30 | 0.020 |
Why?
| Cell Movement | 1 | 2011 | 950 | 0.020 |
Why?
| Blood Vessels | 1 | 2008 | 187 | 0.020 |
Why?
| Oxidation-Reduction | 1 | 2010 | 1031 | 0.020 |
Why?
| Heart Failure | 1 | 2019 | 2148 | 0.020 |
Why?
| Microfilament Proteins | 1 | 2007 | 128 | 0.020 |
Why?
| Oxidative Stress | 1 | 2012 | 1264 | 0.020 |
Why?
| Antioxidants | 1 | 2009 | 558 | 0.020 |
Why?
| Muscle Proteins | 1 | 2007 | 222 | 0.010 |
Why?
| Green Fluorescent Proteins | 1 | 2006 | 390 | 0.010 |
Why?
| Recombinant Proteins | 1 | 2008 | 1311 | 0.010 |
Why?
| Dietary Fats | 1 | 2006 | 303 | 0.010 |
Why?
| Kidney | 1 | 2012 | 1383 | 0.010 |
Why?
| Base Sequence | 1 | 2008 | 2142 | 0.010 |
Why?
| O(6)-Methylguanine-DNA Methyltransferase | 1 | 2003 | 6 | 0.010 |
Why?
| Carmustine | 1 | 2003 | 50 | 0.010 |
Why?
| Metabolic Clearance Rate | 1 | 2003 | 117 | 0.010 |
Why?
| Antineoplastic Agents, Alkylating | 1 | 2003 | 67 | 0.010 |
Why?
| Half-Life | 1 | 2003 | 162 | 0.010 |
Why?
| Cell Survival | 1 | 2006 | 1086 | 0.010 |
Why?
| Proto-Oncogene Proteins c-kit | 1 | 2003 | 63 | 0.010 |
Why?
| Carrier Proteins | 1 | 2006 | 741 | 0.010 |
Why?
| Infusions, Intravenous | 1 | 2003 | 402 | 0.010 |
Why?
| Molecular Probes | 1 | 2002 | 36 | 0.010 |
Why?
| Radiation Chimera | 1 | 2001 | 30 | 0.010 |
Why?
| Cell Transplantation | 1 | 2001 | 37 | 0.010 |
Why?
| Organ Specificity | 1 | 2001 | 295 | 0.010 |
Why?
| Myocardial Reperfusion Injury | 1 | 2001 | 129 | 0.010 |
Why?
| Myocardial Ischemia | 1 | 2001 | 259 | 0.010 |
Why?
| United States | 1 | 2016 | 13913 | 0.010 |
Why?
| Chick Embryo | 1 | 1999 | 130 | 0.010 |
Why?
| Graft Survival | 1 | 2001 | 514 | 0.010 |
Why?
| Hypoglycemic Agents | 1 | 2006 | 1221 | 0.010 |
Why?
| Rabbits | 1 | 1999 | 778 | 0.010 |
Why?
|
|
Majka's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|